Welcome to LookChem.com Sign In|Join Free
  • or
N4,O3'-dibenzoyl-O5'-(toluene-4-sulfonyl)-2'deoxy-cytidine is a complex organic compound that belongs to the class of nucleoside derivatives. It is characterized by a cytidine molecule, which is a type of nucleoside, with specific modifications. The cytidine base is attached to a 2'-deoxyribose sugar, which lacks an oxygen atom at the 2' position, making it a 2'-deoxy derivative. N4,O3'-dibenzoyl-O5'-(toluene-4-sulfonyl)-2'deoxy-cytidine is further modified with a dibenzoyl group at the N4 position and an O3' position, and a toluene-4-sulfonyl group at the O5' position. These modifications can affect the compound's chemical reactivity, stability, and potential biological activity. Such compounds are often studied for their potential applications in medicinal chemistry, particularly in the development of antiviral or anticancer drugs, due to their ability to interact with nucleic acids.

4836-14-0

Post Buying Request

4836-14-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4836-14-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4836-14-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,3 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4836-14:
(6*4)+(5*8)+(4*3)+(3*6)+(2*1)+(1*4)=100
100 % 10 = 0
So 4836-14-0 is a valid CAS Registry Number.

4836-14-0Downstream Products

4836-14-0Relevant academic research and scientific papers

NOVEL MODULATORS OF CELL CYCLE CHECKPOINTS AND THEIR USE IN COMBINATION WITH CHECKPOINT KINASE INHIBITORS

-

Page/Page column 94, (2009/06/27)

In its many embodiments, the present invention provides a novel class of pyrimidine analogs of formula (V) as targeted mechanism-based modulators of cell cycle checkpoints. Cancers and/or malignancies can be treated by administration of a cell cycle checkpoint modulator of the invention. Also discussed are suitable combinations of the cell cycle checkpoint modulator with a checkpoint kinase inhibitor to produce synergistic apoptosis in cancer cells. The invention includes methods of treating cancers by administering the combination of the cell cycle checkpoint modulator and the checkpoint kinase inhibitor, pharmaceutical compositions comprising the activator as well as the combination and pharmaceutical kits

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4836-14-0